Tempus AI Stock Faces a Make-or-Break Moment After Its Recent Pullback

Tempus AI (TEM) may be building one of healthcare's fastest-growing artificial intelligence (AI) platforms, but the stock hasn't given investors much to celebrate lately. Shares are down roughly 15% over the past year and about 4% year-to-date (YTD), even as the company continues to report strong revenue growth and expand its footprint in AI-powered precision medicine. TEM stock even has an approximately 4% weightage in Cathie Wood's ARK Invest ETFs (ARKG) (ARKK). With the stock pulling back while the fundamentals continue improving, investors are left with a critical choice.

Does this pullback represent a buying opportunity or a warning sign?

Billionaire Mark Cuban Asks If AI 'Collapses' And Data Centers Turn Into 'Chuck E Cheeses,' Would That 'Create A Revival Of Jobs?'

As Trump Doubles Down on Quantum Computing, This Is the Top-Performing Stock to Buy YTD

Why Verizon, AT&T, and T-Mobile Should Be Terrified of Elon Musk's Next Move

Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today!

Previously, diagnostic companies cared mostly about selling

Fuente original: Yahoo Finance (https://finance.yahoo.com/healthcare/articles/tempus-ai-stock-faces-break-143607247.html)